• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氧基聚乙二醇链长度和分子结构对免疫聚乙二醇脂质体靶向淋巴结的影响。

The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes.

作者信息

Moghimi S M

机构信息

Molecular Targeting and Polymer Toxicology Group, School of Pharmacy, University of Brighton, Brighton BN2 4GJ, UK.

出版信息

Biomaterials. 2006 Jan;27(1):136-44. doi: 10.1016/j.biomaterials.2005.05.082.

DOI:10.1016/j.biomaterials.2005.05.082
PMID:16019063
Abstract

The rate of drainage and lymphatic distribution of subcutaneously injected liposomes is controlled by inclusion of methoxypoly(ethyleneglycol), mPEG-phospholipid into the liposomal bilayer. The effect is most dramatic with liposomes containing 15 mol% mPEG-lipid, with an average PEG molecular mass of 350 Da. These vesicles are drained rapidly from the injection site into the initial lymphatics when compared to unmodified liposomes, and are retained more favourably by the scavengers of the regional lymph node. Liposomes decorated with longer surface mPEG chains (6.7 mol% of mPEG2000-lipid) exhibit faster drainage rates than vesicles having 15 mol% mPEG350-lipid in their lipid bilayer, but their lymph node retention is very poor. The lymph node retention of rapidly drained PEG-bearing vesicles was increased dramatically following conjugation of a non-specific IgG to the distal end of PEG, using a functionalized PEG2000 lipid. Adjusting the molecular architecture of surface mPEG and IgG-PEG chains to a "nearly overlapped mushroom" regime further enhanced target recognition of immuno-PEG2000 liposomes without compromising their drainage rate from the interstitium. The lymph node retention of these vesicles was further optimized by enriching their lipid bilayer with 20 mol% phosphatidylserine. These approaches have established important compositional and structural variables that control lymphatic targeting of immuno-PEG liposomes and their application in experimental medicine and biology is discussed.

摘要

皮下注射脂质体的引流速率和淋巴分布是通过将甲氧基聚乙二醇(mPEG)-磷脂包含在脂质体双层中来控制的。对于含有15摩尔% mPEG-脂质且平均PEG分子量为350 Da的脂质体,这种效果最为显著。与未修饰的脂质体相比,这些囊泡从注射部位迅速引流到初始淋巴管中,并被区域淋巴结的清除剂更有利地保留。表面mPEG链较长(mPEG2000-脂质占6.7摩尔%)的脂质体比脂质双层中含有15摩尔% mPEG350-脂质的囊泡表现出更快的引流速率,但其在淋巴结中的保留情况很差。使用功能化的PEG2000脂质将非特异性IgG与PEG的远端偶联后,快速引流的含PEG囊泡在淋巴结中的保留显著增加。将表面mPEG和IgG-PEG链的分子结构调整到“几乎重叠的蘑菇”状态,进一步增强了免疫PEG2000脂质体的靶向识别,同时不影响其从间质的引流速率。通过用20摩尔%的磷脂酰丝氨酸富集其脂质双层,进一步优化了这些囊泡在淋巴结中的保留。这些方法确定了控制免疫PEG脂质体淋巴靶向的重要组成和结构变量,并讨论了它们在实验医学和生物学中的应用。

相似文献

1
The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes.甲氧基聚乙二醇链长度和分子结构对免疫聚乙二醇脂质体靶向淋巴结的影响。
Biomaterials. 2006 Jan;27(1):136-44. doi: 10.1016/j.biomaterials.2005.05.082.
2
Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.免疫聚乙二醇脂质体的淋巴靶向性:抗体偶联程序对淋巴结巨噬细胞摄取的评估
J Drug Target. 2008 Aug;16(7):586-90. doi: 10.1080/10611860802228905.
3
Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation.通过五聚体IgM抗体介导的囊泡聚集增强皮下注射的IgG1-PEG2000-脂质体在淋巴结中的滞留
Biochim Biophys Acta. 2008 Jan;1778(1):51-5. doi: 10.1016/j.bbamem.2007.08.033. Epub 2007 Sep 14.
4
Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.聚乙二醇-脂质缀合物可调节由磷脂酰乙醇胺和磷脂酰丝氨酸组成的脂质体的钙诱导融合。
Biochemistry. 1996 Feb 27;35(8):2618-24. doi: 10.1021/bi952000v.
5
Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.接枝聚乙二醇对脂质体大小以及脂质双分子层的压缩性和堆积的影响。
Chem Phys Lipids. 2005 Jun;135(2):117-29. doi: 10.1016/j.chemphyslip.2005.02.003. Epub 2005 Mar 2.
6
The encapsulation and release of guanosine from PEGylated liposomes.聚乙二醇化脂质体对鸟苷的包封与释放
J Liposome Res. 2009;19(1):29-36. doi: 10.1080/08982100802673940.
7
Dynamic and structural aspects of PEGylated liposomes monitored by NMR.通过核磁共振监测聚乙二醇化脂质体的动态和结构方面。
J Colloid Interface Sci. 2008 Sep 15;325(2):485-93. doi: 10.1016/j.jcis.2008.05.051. Epub 2008 Jun 3.
8
Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.磷脂 - 甲氧基(聚乙二醇)共轭物的磷酸氧部分甲基化可防止聚乙二醇化脂质体介导的补体激活和过敏毒素产生。
FASEB J. 2006 Dec;20(14):2591-3. doi: 10.1096/fj.06-6186fje. Epub 2006 Oct 25.
9
Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.在聚合物链末端连接有寡肽或寡糖配体的聚乙二醇接枝脂质体。
Bioconjug Chem. 1997 Mar-Apr;8(2):111-8. doi: 10.1021/bc9600832.
10
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.重复注射后影响聚乙二醇脂质体血液清除加速的因素。
J Pharmacol Exp Ther. 2001 Aug;298(2):607-12.

引用本文的文献

1
PEGylation technology: addressing concerns, moving forward.聚乙二醇化技术:解决问题,向前迈进。
Drug Deliv. 2025 Dec;32(1):2494775. doi: 10.1080/10717544.2025.2494775. Epub 2025 Apr 23.
2
Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy.用于肿瘤免疫治疗的淋巴结靶向纳米递送系统的新兴策略。
Essays Biochem. 2025 Mar 28;69(2):EBC20253008. doi: 10.1042/EBC20253008.
3
mRNA vaccine designs for optimal adjuvanticity and delivery.mRNA 疫苗设计用于最佳佐剂和传递。
RNA Biol. 2024 Jan;21(1):1-27. doi: 10.1080/15476286.2024.2333123. Epub 2024 Mar 26.
4
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up.用于生物制品递送的脂质纳米颗粒的化学与研发工艺:聚焦于研发与放大生产
Pharmaceutics. 2024 Jan 19;16(1):131. doi: 10.3390/pharmaceutics16010131.
5
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy.基于纳米疫苗的策略用于肿瘤免疫治疗中的淋巴结靶向递药和成像。
J Nanobiotechnology. 2023 Jul 23;21(1):236. doi: 10.1186/s12951-023-01989-x.
6
Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles.调控纳米颗粒补体反应的纳米级和埃级特征。
J Control Release. 2022 Nov;351:432-443. doi: 10.1016/j.jconrel.2022.09.039. Epub 2022 Sep 27.
7
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.临床及临床试验中的脂质纳米颗粒:从癌症纳米医学到新冠疫苗
Vaccines (Basel). 2021 Apr 8;9(4):359. doi: 10.3390/vaccines9040359.
8
Manipulating Phospholipid Vesicles at the Nanoscale: A Transformation from Unilamellar to Multilamellar by an -Alkyl-poly(ethylene oxide).在纳米尺度上操纵磷脂囊泡:- 烷基 - 聚(环氧乙烷)将单层囊泡转化为多层囊泡。
Langmuir. 2021 Feb 23;37(7):2362-2375. doi: 10.1021/acs.langmuir.0c03302. Epub 2021 Feb 11.
9
Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma.纳米结构 SL9-CpG 脂质体疫苗引发免疫应答,用于治疗黑色素瘤。
Int J Mol Sci. 2019 May 5;20(9):2207. doi: 10.3390/ijms20092207.
10
The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses.纳米医学性能与反应中血液蛋白、补体与巨噬细胞的相互作用。
J Pharmacol Exp Ther. 2019 Sep;370(3):581-592. doi: 10.1124/jpet.119.258012. Epub 2019 Apr 2.